z-logo
open-access-imgOpen Access
Performance of Repeat BinaxNOW Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Testing in a Community Setting, Wisconsin, November 2020–December 2020
Author(s) -
Melisa M. Shah,
Phillip P. Salvatore,
Laura Ford,
Emiko Kamitani,
Melissa Whaley,
Kaitlin F. Mitchell,
Dustin W. Currie,
Clint N. Morgan,
Hannah E. Segaloff,
Shirley Lee Lecher,
Tarah Somers,
Miriam E. Van Dyke,
John Paul Bigouette,
Augustina Delaney,
Juliana DaSilva,
Michelle O’Hegarty,
Lauren Boyle-Estheimer,
Fatima Abdirizak,
Sandor E. Karpathy,
Jennifer K. Meece,
Lynn Ivanic,
Kimberly Goffard,
Doug Gieryn,
Alana K. Sterkel,
Allen C. Bateman,
Juliana Kahrs,
Kimberly Langolf,
Tara Zochert,
Nancy Knight,
Christopher H. Hsu,
Hannah L. Kirking,
Jacqueline E. Tate
Publication year - 2021
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab309
Subject(s) - medicine , concordance , covid-19 , antigen , respiratory system , coronavirus , immunology , virology , disease , outbreak , infectious disease (medical specialty)
Repeating the BinaxNOW antigen test for severe acute respiratory syndrome coronavirus 2 using 2 groups of readers within 30 minutes resulted in high concordance (98.9%) in 2110 encounters. Same-day repeat antigen testing did not significantly improve test sensitivity (77.2% to 81.4%) while specificity remained high (99.6%).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom